Stock Scorer

National Healthcare Properties, Inc. (HLTC)

National Healthcare Properties, Inc. reported revenue of 87.5M USD for the quarter ending 30 June 2026, up 2.6% from 85.3M a year earlier.

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than filled in. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD. The same series drawn ›

As last reported

The newest period the filing supports for each figure, in USD.
FigurePeriodAmountYear on year
Revenue Q2 '26 · ending 30 June 2026 87.5M +2.6%
Gross Profit Q2 '26 · ending 30 June 2026 33.4M +7.2%
Operating Income Q2 '26 · ending 30 June 2026 5.1M —
Net Income Q2 '26 · ending 30 June 2026 -5.4M —
Operating Cash Flow Q2 '26 · ending 30 June 2026 21.6M +168.3%
Free Cash Flow Q2 '26 · ending 30 June 2026 16.3M +1099.3%
Shares Outstanding Q2 '26 · ending 30 June 2026 61.6M +117.7%
EPS Q2 '26 · ending 30 June 2026 -1.88 —

Revenue and profit by financial year

As filed, in USD. A year the filing does not support is not listed.
YearEnding RevenueOperating IncomeNet IncomeFree Cash Flow
20252025-12-31 342.3M3.3M-57.7M-21.8M
20242024-12-31 353.8M-123.5M-190.3M-101.8M
20232023-12-31 345.9M-4.7M-72.4M-773K
20222022-12-31 335.8M-31.5M-79.6M302K
20212021-12-31 329.4M-37.4M-85.4M19.8M
20202020-12-31 381.6M-19.9M-75.5M19.9M
20192019-12-31 374.9M-31.8M-88.1M30.7M
20182018-12-31 362.4M-3.2M-52.8M41.2M
20172017-12-31 311.2M-12.2M-42.5M55.7M
20162016-12-31 302.6M-3.3M-20.9M71.2M

Every period

Revenue Quarterly

PeriodEndingRevenue
Q2 '262026-06-3087.5M
Q1 '262026-03-3186.3M
Q4 '252025-12-3184.5M
Q3 '252025-09-3086M
Q2 '252025-06-3085.3M
Q1 '252025-03-3186.4M
Q4 '242024-12-3187.7M
Q3 '242024-09-3088.9M
Q2 '242024-06-3088.8M
Q1 '242024-03-3188.3M
Q4 '232023-12-3186.8M
Q3 '232023-09-3085.7M
Q2 '232023-06-3086.1M
Q1 '232023-03-3187.4M
Q4 '222022-12-3184.9M
Q3 '222022-09-3083.5M
Q2 '222022-06-3083.8M
Q1 '222022-03-3183.7M
Q4 '212021-12-3182.8M
Q3 '212021-09-3082M

Gross Profit Quarterly

PeriodEndingGross Profit
Q2 '262026-06-3033.4M
Q1 '262026-03-3133.4M
Q4 '252025-12-3131.5M
Q3 '252025-09-3032.2M
Q2 '252025-06-3031.2M
Q1 '252025-03-3128.6M
Q4 '242024-12-3132.8M
Q3 '242024-09-3032.5M
Q2 '242024-06-3033.8M
Q1 '242024-03-3133.2M
Q4 '232023-12-3130.8M
Q3 '232023-09-3031.4M
Q2 '232023-06-3032.5M
Q1 '232023-03-3133.5M
Q4 '222022-12-3128.3M
Q3 '222022-09-3032.3M
Q2 '222022-06-3031.2M
Q1 '222022-03-3130.6M
Q4 '212021-12-3129.1M
Q3 '212021-09-3030.8M

Operating Income Quarterly

PeriodEndingOperating Income
Q2 '262026-06-305.1M
Q1 '262026-03-3110.1M
Q4 '252025-12-31-6.6M
Q3 '252025-09-302.4M
Q2 '252025-06-30-5.5M
Q1 '252025-03-3113M
Q4 '242024-12-31-1.1M
Q3 '242024-09-30-20.9M
Q2 '242024-06-30-100.4M
Q1 '242024-03-31-1.1M
Q4 '232023-12-31-6.6M
Q3 '232023-09-30-912K
Q2 '232023-06-30813K
Q1 '232023-03-311.9M
Q4 '222022-12-31-4.7M
Q3 '222022-09-30-8.3M
Q2 '222022-06-30-5.9M
Q1 '222022-03-31-12.6M
Q4 '212021-12-31-7.6M
Q3 '212021-09-30-28.6M

Net Income Quarterly

PeriodEndingNet Income
Q2 '262026-06-30-5.4M
Q1 '262026-03-31-4.3M
Q4 '252025-12-31-22.8M
Q3 '252025-09-30-12.5M
Q2 '252025-06-30-20.8M
Q1 '252025-03-31-1.5M
Q4 '242024-12-31-17M
Q3 '242024-09-30-40.8M
Q2 '242024-06-30-116.9M
Q1 '242024-03-31-15.6M
Q4 '232023-12-31-24.9M
Q3 '232023-09-30-16.1M
Q2 '232023-06-30-17.3M
Q1 '232023-03-31-14.1M
Q4 '222022-12-31-18.7M
Q3 '222022-09-30-19.9M
Q2 '222022-06-30-17.6M
Q1 '222022-03-31-23.4M
Q4 '212021-12-31-19.4M
Q3 '212021-09-30-40.5M

Operating Cash Flow Quarterly

PeriodEndingOperating Cash Flow
Q2 '262026-06-3021.6M
Q1 '262026-03-319M
Q4 '252025-12-3110M
Q3 '252025-09-3010.2M
Q2 '252025-06-308.1M
Q1 '252025-03-31-21.2M
Q4 '242024-12-316.5M
Q3 '242024-09-30-95.2M
Q2 '242024-06-306.4M
Q1 '242024-03-312.5M
Q4 '232023-12-315.3M
Q3 '232023-09-305.7M
Q2 '232023-06-305.7M
Q1 '232023-03-315M
Q4 '222022-12-317.2M
Q3 '222022-09-307.4M
Q2 '222022-06-307.9M
Q1 '222022-03-315.9M
Q4 '212021-12-3112.9M
Q3 '212021-09-308.4M

Free Cash Flow Quarterly

Operating cash flow minus capital expenditure.

PeriodEndingFree Cash Flow
Q2 '262026-06-3016.3M
Q1 '262026-03-313.7M
Q4 '252025-12-31-1.8M
Q3 '252025-09-305.6M
Q2 '252025-06-301.4M
Q1 '252025-03-31-26.9M
Q4 '242024-12-31946K
Q3 '242024-09-30-100.5M
Q2 '242024-06-30393K
Q1 '242024-03-31-2.6M
Q4 '232023-12-31-3.1M
Q3 '232023-09-30823K
Q2 '232023-06-30182K
Q1 '232023-03-311.4M
Q4 '222022-12-31-4.1M
Q3 '222022-09-30-274K
Q2 '222022-06-302.1M
Q1 '222022-03-312.6M
Q4 '212021-12-315.3M
Q3 '212021-09-304.1M

Shares Outstanding Quarterly

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

PeriodEndingShares Outstanding
Q2 '262026-06-3061.6M
Q1 '262026-03-3128.3M
Q3 '252025-09-3028.3M
Q2 '252025-06-3028.3M
Q1 '252025-03-3128.3M
Q3 '242024-09-3028.3M
Q2 '242024-06-3028.3M
Q1 '242024-03-3128.3M
Q3 '232023-09-3028.3M
Q2 '232023-06-30113.1M
Q1 '232023-03-31113.1M
Q3 '222022-09-30111.4M
Q2 '222022-06-30109.7M
Q1 '222022-03-31108M
Q3 '212021-09-30104.9M
Q2 '212021-06-30103.4M
Q1 '212021-03-31101.9M
Q3 '202020-09-3099M
Q2 '202020-06-3097.3M
Q4 '142014-12-3183.4M

EPS TTM

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.

PeriodEndingEPS
Q2 '262026-06-30-1.88
Q1 '262026-03-31-2.60
Q4 '242024-12-31-7.19
Q3 '242024-09-30-7.46
Q2 '242024-06-30-6.59
Q1 '242024-03-31-2.53
Q4 '232023-12-31-2.01
Q3 '232023-09-30-3.68
Q2 '232023-06-30-3.20
Q1 '232023-03-31-3.21
Q4 '222022-12-31-3.31
Q3 '222022-09-30-0.80
Q2 '222022-06-30-0.99
Q1 '222022-03-31-0.95
Q4 '212021-12-31-0.82
Q3 '212021-09-30-0.82
Q2 '212021-06-30-0.53
Q1 '212021-03-31-0.61
Q4 '202020-12-31-0.75
Q3 '202020-09-30-1.11